THE VALUE OF MEDICAL INNOVATION: SAVING LIVES, SAVING MONEY

HINJ President and Chief Executive Officer Dean J. Paranicas has authored an op-ed on the life sciences and the value of medical innovation.

“Medical innovations produced by American life sciences companies have vastly improved the human condition. Our pharmaceutical, biotech, medical technology, device and diagnostics companies have helped people live longer, with less pain and greater quality of life.

“Over the past century, the life sciences has eradicated some of the world’s most dreaded diseases such as polio and smallpox. More recently, the industry has made other diseases such as breast cancer, HIV/AIDS, heart disease and lung cancer no longer the death sentences that they once were.

“With these medical innovations, past and future, comes an often-overlooked benefit: the incalculable billions of dollars in savings to patients, their families, insurers, employers, governments and hospitals in avoided medical expenses associated with keeping people healthy or curing them of a life-long, chronic condition.”

HINJ has created an online portal to HINJ member companies’ myriad corporate social responsibility (CSR) activities, including their corporate philanthropy, patient outreach initiatives and sustainability/green practices.

HINJ OP-ED: LIFE SCIENCES COMMUNITY THRIVING IN NEW JERSEY’S ‘2.0 BUSINESS ENVIRONMENT’

The Asbury Park Press has published an op-ed by HINJ President and Chief Executive Officer Dean Paranicas regarding New Jersey’s “2.0 business environment” and its impact on the state’s life sciences community.

“There have been reports that claim that New Jersey is no longer the pharmaceutical powerhouse it used to be, including a recent Asbury Park Press story by Michael L. Diamond …. We disagree. To paraphrase Mark Twain, reports of New Jersey’s demise are greatly exaggerated.

“For decades, New Jersey has rightly earned its reputation as the ‘Medicine Chest of the World’ — and our state leaders are working with the life sciences industry to keep it that way.

Mindful of the life sciences’ significant contributions to the state’s economy and global human health, Governor Christie and his economic development team, together with the State Legislature and its leadership, both Democrats and Republicans, have worked diligently over the past few years to enhance the state’s business climate to retain and grow the many life sciences companies that call New Jersey home — and attract new industry investment.

On June 13, the HealthCare Institute of New Jersey (HINJ) hosted a roundtable discussion featuring New Jersey Lt. Governor Kim Guadagno on the state of the life sciences and prospects for industry growth in the Garden State as part of the HINJ Board of Trustees meeting.

HINJ Honors Six at Inaugural Life Sciences Celebration

The HealthCare Institute of New Jersey (HINJ) honored five New Jersey leaders and a nationally recognized high school on September 25, 2013, for their contributions in human health, public service, patient advocacy, life sciences, and science, technology, engineering and mathematics (STEM) education.

The awards were presented at HINJ’s inaugural Life Sciences Celebration, which was held at the Renaissance Woodbridge Hotel in Iselin, NJ.